Tierney D W
VA Outpatient Clinic, Boston, MA 02108.
J Am Optom Assoc. 1987 Sep;58(9):722-7.
The Food and Drug Administration has recently approved the use of two new ophthalmic beta-adrenergic antagonistic agents: betaxolol hydrochloride (Betoptic) and levobunolol hydrochloride (Betagan). This paper reviews the history, pharmacologic properties, clinical efficacy and potential side effects of this expanding class of antiglaucoma medication.
美国食品药品监督管理局最近批准了两种新型眼科β-肾上腺素能拮抗剂的使用：盐酸倍他洛尔（Betoptic）和盐酸左布诺洛尔（Betagan）。本文综述了这类不断扩充的抗青光眼药物的历史、药理特性、临床疗效及潜在副作用。
